Mechanism of osteonecrosis induced by provoke bone-loss: A rondomized control study

Chinese Journal of Clinical Rehabilitation

Volumn 8, Issue 15, 2004, Pages 2900-2901

  Chi, Zhi Yong ^a   Wang, Yan ^a   Han, Gang ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; OSTEOPROTEGERIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE BIOPSY; BONE DENSITY; BONE MINERAL; CELL PROLIFERATION; CONTROLLED STUDY; DENSITOMETRY; FEMUR HEAD; FEMUR HEAD NECROSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MOLECULAR MECHANICS; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PROTEIN EXPRESSION; RABBIT; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

EID: 3543084475     PISSN: 16715926     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Chinese source. 2003; 7(11):1624-5
2. Chinese source. 2003; 7(12):1781-3
3. Yamamoto T, Hirano K, Tsutsui H, et al. Corticosteroid enhances the experimental induction of osteonecrosis in rabbits with shwartzman reaction. Clinical Orthop 1995; (316):235-43
4. Simonet WS, Lacey DL, Cunstan CR, et al. Osetoprotegerin: A novel secreted protein involved in the regulation of bone density. Cell 1997; 89; 309-19
5. Chinese source. 2003; 7(29): 3948-9
6. Yasuda H, Shima N, Nakagawa N, et al. A Novel Molelar mechanism modulating osteoclast differentiation and function. Bone 1999; 25: 109-13
7. Yasuda H, Shima N, Nakagawa N, et al. Identity of Osteoclastogenesis inhibitory factor(OCIF) and osteoprotegerin(OPG): A mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. Endocrinology 1998; 139: 1329-37
8. Lacey DL, Timms E, Tan HL, et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998; 93: 165-76
9. Hofbauer LC, Gorl F, Riggs BL, et al. timulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocoticoid-induced osteoporosis. Endocrinology 1999; 140 (10): 4382-9
10. Weinstein RS, Jilka RL, Parfitt AM, et al. Inhibition of osteoblastogenesis and promotion apoptosis of osteoblasts and osteocytes by glucocoticoids. J Clin Inves 1998; 102 (2): 274-82